Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
PCVX

Vaxcyte (PCVX) stock: insider trades, news & valuation

Heavy selling
Close · Oct 9, 2026 $71.38 +9.8% on the day +70.0% over 12 months 52-week range $40.32 – $73.82

Share price and insider trades

PCVX closeInsider buyInsider sale
4050607080NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $79,400 on 2026-09-09 · Jim WassilSold $84,462 on 2026-09-04 · Jim WassilSold $105,150 on 2026-03-17 · Elvia CowanSold $111,409 on 2026-06-01 · Jim WassilSold $126,735 on 2026-07-01 · Jim WassilSold $127,513 on 2026-10-01 · Jim WassilSold $127,868 on 2026-05-01 · Jim WassilSold $131,477 on 2026-04-01 · Jim WassilSold $146,475 on 2026-03-11 · Elvia CowanSold $180,000 on 2026-04-07 · Elvia CowanSold $212,360 on 2026-09-01 · Jim WassilSold $435,450 on 2026-03-10 · Jim WassilSold $454,901 on 2025-12-31 · Harpreet S. DhaliwalSold $557,010 on 2025-12-23 · Elvia CowanSold $572,852 on 2026-07-06 · Andrew GuggenhimeSold $660,073 on 2026-08-03 · Andrew Guggenhime, Jim WassilSold $935,000 on 2026-08-05 · Harpreet S. DhaliwalSold $1,012,430 on 2026-07-27 · Grant PickeringSold $1,338,347 on 2026-06-26 · Grant PickeringSold $1,814,205 on 2026-06-18 · Andrew Guggenhime, Grant PickeringSold $3,209,380 on 2026-10-05 · Elvia Cowan, Jim Wassil
Bought, 12 months$0
Sold, 12 months$12.4M
Insiders buying0
Insiders selling5

Vaxcyte insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 5 sold $12.4M of PCVX stock on the open market.

PCVX insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $1.0M sold (3 trades)Q4 2025Q1 2026: $687K sold (5 trades)Q1 2026Q2 2026: $3.7M sold (20 trades)Q2 2026Q3 2026: $3.7M sold (22 trades)Q3 2026Q4 2026: $3.3M sold (4 trades)Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0$3.3M4
Q3 2026—0$3.7M22
Q2 2026—0$3.7M20
Q1 2026—0$687K5
Q4 2025—0$1.0M3

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day7.5×Last 5 sessions
Insiders' paper profit—On all tracked purchases —

Summary

Over the past 12 months, 0 Vaxcyte, Inc. insiders reported open-market purchases totaling $0, while 5 insiders reported sales totaling $12.4M. 51 of 54 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Oct 7SEC Elvia CowanSvp, Finance & Cao Sell Plan 19,00027,860 held (−41%) $86.74 $1.6M -17.7% —
Oct 7SEC Jim WassilCOO Sell Plan 18,000145,435 held (−11%) $86.74 $1.6M -17.7% —
Oct 2SEC Jim WassilCOO Sell Plan 2,155145,530 held (−1%) $56.65 $122K +26.0% —
Oct 2SEC Jim WassilCOO Sell Plan 95145,435 held (−0%) $57.09 $5K +25.0% —
Sep 9SEC Jim WassilCOO Sell Plan 1,381152,228 held (−1%) $61.16 $84K +16.7% —
Sep 9SEC Jim WassilCOO Sell Plan 1,334145,435 held (−1%) $59.52 $79K +19.9% —
Sep 2SEC Jim WassilCOO Sell Plan 1,537156,981 held (−1%) $60.89 $94K +17.2% —
Sep 2SEC Jim WassilCOO Sell Plan 924155,344 held (−1%) $60.96 $56K +17.1% —
Sep 2SEC Jim WassilCOO Sell Plan 713156,268 held (−0%) $61.48 $44K +16.1% —
Sep 2SEC Jim WassilCOO Sell Plan 303155,041 held (−0%) $61.42 $19K +16.2% —
Aug 5SEC Harpreet S. DhaliwalChief Technical Ops Officer Sell Plan 17,00076,756 held (−18%) $55.00 $935K +29.8% —
Aug 5SEC Andrew GuggenhimeCFO, President Sell Plan 6,956108,220 held (−6%) $53.76 $374K +32.8% —
Aug 5SEC Andrew GuggenhimeCFO, President Sell Plan 3,044105,176 held (−3%) $54.18 $165K +31.7% —
Aug 5SEC Jim WassilCOO Sell Plan 1,389157,541 held (−1%) $54.09 $75K +32.0% —
Aug 5SEC Jim WassilCOO Sell Plan 861158,930 held (−1%) $53.50 $46K +33.4% —
Jul 28SEC Grant PickeringCEO Sell Plan 11,783457,662 held (−3%) $55.52 $654K +28.6% —
Jul 28SEC Grant PickeringCEO Sell Plan 4,415453,247 held (−1%) $55.93 $247K +27.6% —
Jul 28SEC Grant PickeringCEO Sell Plan 756133,459 held (−1%) $55.52 $42K +28.6% —
Jul 28SEC Grant PickeringCEO Sell Plan 622133,593 held (−0%) $55.54 $35K +28.5% —
Jul 28SEC Grant PickeringCEO Sell Plan 378133,215 held (−0%) $55.91 $21K +27.7% —
Jul 28SEC Grant PickeringCEO Sell Plan 244133,215 held (−0%) $55.96 $14K +27.6% —
Jul 6SEC Andrew GuggenhimeCFO, President Sell Plan 7,913106,482 held (−7%) $57.16 $452K +24.9% —
Jul 6SEC Andrew GuggenhimeCFO, President Sell Plan 2,087104,395 held (−2%) $57.76 $121K +23.6% —
Jul 6SEC Jim WassilCOO Sell Plan 1,788157,222 held (−1%) $56.03 $100K +27.4% —
Jul 6SEC Jim WassilCOO Sell Plan 456156,766 held (−0%) $57.47 $26K +24.2% —
Jul 6SEC Jim WassilCOO Sell Plan 6156,760 held (−0%) $57.82 $347 +23.5% —
Jun 26SEC Grant PickeringCEO Sell Plan 9,137458,883 held (−2%) $55.27 $505K +29.1% —
Jun 26SEC Grant PickeringCEO Sell Plan 6,683468,020 held (−1%) $54.28 $363K +31.5% —
Jun 26SEC Grant PickeringCEO Sell Plan 6,417452,466 held (−1%) $56.12 $360K +27.2% —
Jun 26SEC Grant PickeringCEO Sell Plan 602134,406 held (−0%) $55.30 $33K +29.1% —
Jun 26SEC Grant PickeringCEO Sell Plan 356134,547 held (−0%) $55.23 $20K +29.2% —
Jun 26SEC Grant PickeringCEO Sell Plan 332134,215 held (−0%) $55.99 $19K +27.5% —
Jun 26SEC Grant PickeringCEO Sell Plan 312134,903 held (−0%) $54.35 $17K +31.3% —
Jun 26SEC Grant PickeringCEO Sell Plan 207135,008 held (−0%) $54.22 $11K +31.6% —
Jun 26SEC Grant PickeringCEO Sell Plan 191134,215 held (−0%) $56.27 $11K +26.9% —
Jun 18SEC Grant PickeringCEO Sell Plan 22,236474,703 held (−4%) $52.50 $1.2M +36.0% —
Jun 18SEC Andrew GuggenhimeCFO, President Sell Plan 10,000104,395 held (−9%) $53.00 $530K +34.7% —
Jun 18SEC Grant PickeringCEO Sell Plan 1,000135,215 held (−1%) $52.50 $52K +36.0% —
Jun 18SEC Grant PickeringCEO Sell Plan 1,000135,215 held (−1%) $52.50 $52K +36.0% —
Jun 18SEC Grant PickeringCEO Sell Plan 225496,939 held (−0%) $52.51 $12K +35.9% —
Jun 3SEC Jim WassilCOO Sell Plan 1,949158,795 held (−1%) $49.40 $96K +44.5% —
Jun 3SEC Jim WassilCOO Sell Plan 301158,494 held (−0%) $50.26 $15K +42.0% —
May 1SEC Jim WassilCOO Sell Plan 2,250160,744 held (−1%) $56.83 $128K +25.6% —
Apr 8SEC Elvia CowanSvp, Finance & Cao Sell Plan 3,00028,975 held (−9%) $60.00 $180K +19.0% —
Apr 3SEC Jim WassilCOO Sell Plan 1,412165,406 held (−1%) $58.14 $82K +22.8% —
Apr 3SEC Jim WassilCOO Sell Plan 838162,994 held (−1%) $58.93 $49K +21.1% —
Mar 18SEC Elvia CowanSvp, Finance & Cao Sell Plan 1,48729,380 held (−5%) $55.39 $82K +28.9% —
Mar 18SEC Elvia CowanSvp, Finance & Cao Sell Plan 40528,975 held (−1%) $56.26 $23K +26.9% —
Mar 11SEC Jim WassilCOO Sell Plan 4,968166,818 held (−3%) $59.16 $294K +20.7% —
Mar 11SEC Elvia CowanSvp, Finance & Cao Sell Plan 2,50030,867 held (−7%) $58.59 $146K +21.8% —
Mar 11SEC Jim WassilCOO Sell Plan 2,427171,786 held (−1%) $58.32 $142K +22.4% —
Jan 2SEC Harpreet S. DhaliwalChief Technical Ops Officer Sell 9,74323,928 held (−29%) $46.69 $455K +52.9% —
Dec 29SEC Elvia CowanSvp, Finance Sell 6,71614,534 held (−32%) $47.94 $322K +48.9% —
Dec 29SEC Elvia CowanSvp, Finance Sell 4,90721,250 held (−19%) $47.90 $235K +49.0% —

Insiders at Vaxcyte, Inc.

InsiderBoughtSoldLast filingScore
Grant PickeringCEO — $3.6M Jul 28, 2026 —
Jim WassilCOO — $3.1M Oct 7, 2026 —
Elvia CowanSvp, Finance & Cao — $2.6M Oct 7, 2026 —
Andrew GuggenhimeCFO, President — $1.6M Aug 5, 2026 —
Harpreet S. DhaliwalChief Technical Ops Officer — $1.4M Aug 5, 2026 —

PCVX stock: common questions

Are Vaxcyte, Inc. insiders buying PCVX stock?

In the past 12 months, 0 insiders reported open-market purchases of PCVX worth $0.

Are Vaxcyte, Inc. insiders selling PCVX stock?

5 insiders reported sales worth $12.4M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is PCVX's 52-week range?

Over the past year PCVX has traded between $40.32 and $73.82. It last closed at $71.38 on Oct 9, 2026.